Shares of Tempus AI (NASDAQ: TEM) were skyrocketing 16.5% higher as of 10:39 a.m. ET on Wednesday. The big gain came after the healthcare artificial intelligence (AI) company announced a multiyear ...

In this video, I will talk about Tempus AI (NASDAQ: TEM) and the recent short-seller report. Watch the short video to learn more, consider subscribing, and click the special offer link below.

Amid a bullish backdrop for the broader market, Tempus AI (NASDAQ: TEM) stock is posting big gains Wednesday. The company's share price was up 15.8% as of 1:45 p.m. ET. At the same point in time ...

In the last three months, 9 analysts have published ratings on Tempus AI (NASDAQ:TEM), offering a diverse range of perspectives from bullish to bearish. The table below provides a snapshot of ...

In mid-August, around two months after Tempus AI’s (NASDAQ: TEM) initial public offering (IPO), the stock was up a marvelous 93%. However, shares have experienced wild volatility and are now 8% ...

Extending the more-than-4% slide that they experienced last week, shares of Tempus AI (NASDAQ: TEM) have suffered an even more precipitous decline this week. According to data provided by S&P ...

Tempus AI offers strong long-term potential fueled by genomics growth, expanding data services and a major AI partnership with AstraZeneca. However, this Zacks Rank #3 (Hold) stock trades at a ...

Short-selling and dilution are among the factors pressuring Tempus AI stock in 2025. Short interest reported in April was high at 26% and rising compared to the previous month, creating a headwind ...

Earnings estimates for Tempus AI have improved from a loss of $2.64 per share to a loss of $1.51 per share for 2024 over the past 60 days, with four upward revisions in contrast to no downward ...

Tempus AI, Inc. TEM recently announced a collaboration with Genialis, the RNA-biomarker company. The multi-year agreement allows Genialis to leverage Tempus’ multimodal dataset to develop new ...

Present Market Standing of Tempus AI Currently trading with a volume of 10,924,277, the TEM's price is down by -4.54%, now at $52.35. RSI readings suggest the stock is currently may be overbought.

Tempus Ai (NASDAQ: TEM) stock is seeing an explosive valuation surge in Tuesday's trading thanks to a pair of catalysts. The healthcare software company's share price was up 35.8% as of 3:15 p.m ...